AHR and hematoma: The main hypothesis of this study was that the activation of AhR in MMΦ after ICH represents a novel therapeutic target for post-ICH recovery, based on AhR’ ability to improve MMΦ self-defense from toxic byproducts of erythrophagocytosis, thereby leading to more effective hematoma cleanup, which is needed for brain repair and functional recovery.